Suppr超能文献

亚铁盐和铁(III)配合物对缺铁性贫血患儿微量元素状况的影响。

Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.

作者信息

Sözmen Eser Yildirim, Kavakli Kaan, Cetinkaya Bilin, Akçay Yasemin Delen, Yilmaz Deniz, Aydinok Yeşim

机构信息

Department of Biochemistry, Ege University Faculty of Medicine, Izmir, Turkey.

出版信息

Biol Trace Elem Res. 2003 Jul;94(1):79-86. doi: 10.1385/BTER:94:1:79.

Abstract

Iron-deficiency anemia (IDA) is the most common nutritional deficiency in childhood throughout the world. Although it has been shown that IRA is associated with elevated plasma copper and depleted zinc levels in children, there are conflicting results on the effect of iron supplementation on the absorption of these elements. The aim of this study was to investigate the effects of ferrous and ferric iron supplementation on the trace element status in children (n=25, aged 8-168 mo) with IDA. Fourteen of them were treated with ferric hydroxide-polymaltose complex (Ferrum, Vifor, Switzerland) (6 mg/d in the first 3 mo for initial therapy and 3 mg/kg for 3 mo as maintenance); the others were treated with a ferrous sulfate complex (FerroSanol, Schwarz, Germany) (6 mg/d in the first 3 mo for initial therapy and 3 mg/kg for 3 mo as maintenance). Plasma copper, zinc, and ceruloplasmin levels as well as hematological parameters were determined at baseline and the first, third, and sixth month of the treatment period. The hemoglobin and iron levels of patients in both groups were higher in the first and sixth months compared to baseline. Although the ceruloplasmin levels were depleted (48.9 mg/dL vs 41.4 mg/dL, p=0.035) during ferrous iron treatment, the copper and zinc levels remained unchanged. On the other hand, ferric iron supplementation led to an increase in zinc levels in the sixth month of treatment (0.77 mg/L vs 1.0 mg/L, p=0.021). The plasma copper levels were lower in the ferrous iron-treated group at the end of the first month of treatment than in the ferric irontreated group (1.06 mg/L vs 1.29 mg/L, p=0.008). In conclusion, our data showed that copper and ceruloplasmin metabolisms were affected by ferrous iron supplementation, whereas ferric iron kept them to normal levels of zinc, possibly by affecting their absorption. We conclude that the copper and zinc status of patients with IDA should be taken into consideration before and after iron therapy.

摘要

缺铁性贫血(IDA)是全球儿童中最常见的营养缺乏症。尽管已有研究表明,儿童缺铁性贫血与血浆铜升高和锌水平降低有关,但关于铁补充剂对这些元素吸收的影响,研究结果存在矛盾。本研究的目的是调查补充亚铁和铁对缺铁性贫血儿童(n = 25,年龄8 - 168个月)微量元素状况的影响。其中14名儿童接受氢氧化铁 - 聚麦芽糖复合物(Ferrum,Vifor,瑞士)治疗(初始治疗前3个月6毫克/天,维持治疗3个月3毫克/千克);其余儿童接受硫酸亚铁复合物(FerroSanol,Schwarz,德国)治疗(初始治疗前3个月6毫克/天,维持治疗3个月3毫克/千克)。在基线以及治疗期的第1、3和6个月测定血浆铜、锌和铜蓝蛋白水平以及血液学参数。与基线相比,两组患者在第1个月和第6个月时血红蛋白和铁水平均升高。尽管在补充亚铁治疗期间铜蓝蛋白水平降低(48.9毫克/分升对41.4毫克/分升,p = 0.035),但铜和锌水平保持不变。另一方面,补充铁在治疗第6个月时导致锌水平升高(0.77毫克/升对1.0毫克/升,p = 0.021)。在治疗第1个月结束时,亚铁治疗组的血浆铜水平低于铁治疗组(1.06毫克/升对1.29毫克/升,p = 0.008)。总之,我们的数据表明,补充亚铁会影响铜和铜蓝蛋白代谢,而铁可能通过影响其吸收使锌保持在正常水平。我们得出结论,在铁治疗前后应考虑缺铁性贫血患者的铜和锌状况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验